Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Invasive disease-free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor-positive, HER2-negative early breast cancer treated with upfront letrozole: Experiences from the phase IV PreFace trial.
Journal: International journal of cancer
Published: September 20, 2024
Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 08, 2024
Correction: Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care - The PreFace Study.
Journal: Geburtshilfe und Frauenheilkunde
Published: May 01, 2024
Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care - The PreFace Study.
Journal: Geburtshilfe und Frauenheilkunde
Published: November 17, 2023
Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients.
Journal: Breast (Edinburgh, Scotland)
Published: July 14, 2019
Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer.
Journal: Breast cancer research and treatment
Published: October 25, 2018
Preexisting musculoskeletal burden and its development under letrozole treatment in early breast cancer patients.
Journal: International journal of cancer
Published: July 09, 2018
Influence of side-effects on early therapy persistence with letrozole in post-menopausal patients with early breast cancer: Results of the prospective EvAluate-TM study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 07, 2017
Influence of patient and tumor characteristics on early therapy persistence with letrozole in postmenopausal women with early breast cancer: results of the prospective Evaluate-TM study with 3941 patients.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 19, 2017
Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study.
Journal: Breast care (Basel, Switzerland)
Published: December 07, 2016
Interest in Integrative Medicine Among Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study.
Journal: Integrative cancer therapies
Published: September 16, 2016
Last Updated: 09/26/2026